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Background-—Preterm delivery (<37 weeks gestational age) affects 11% of all pregnancies, but data are conﬂicting whether
preterm birth is associated with long-term adverse maternal cardiovascular outcomes. We aimed to systematically evaluate and
summarize the evidence on the relationship between preterm birth and future maternal risk of cardiovascular diseases.
Methods and Results-—A systematic search of MEDLINE and EMBASE was performed to identify relevant studies that evaluated
the association between preterm birth and future maternal risk of composite cardiovascular disease, coronary heart disease,
stroke, and death caused by cardiovascular or coronary heart disease and stroke. We quantiﬁed the associations using random
effects meta-analysis. Twenty-one studies with over 5.8 million women, including over 338 000 women with previous preterm
deliveries, were identiﬁed. Meta-analysis of studies that adjusted for potential confounders showed that preterm birth was
associated with an increased risk of maternal future cardiovascular disease (risk ratio [RR] 1.43, 95% conﬁdence interval [CI], 1.18,
1.72), cardiovascular disease death (RR 1.78, 95% CI, 1.42, 2.21), coronary heart disease (RR 1.49, 95% CI, 1.38, 1.60), coronary
heart disease death (RR 2.10, 95% CI, 1.87, 2.36), and stroke (RR 1.65, 95% CI, 1.51, 1.79). Sensitivity analysis showed that the
highest risks occurred when the preterm deliveries occurred before 32 weeks gestation or were medically indicated.
Conclusions-—Preterm delivery is associated with an increase in future maternal adverse cardiovascular outcomes, including a 2-
fold increase in deaths caused by coronary heart disease. These ﬁndings support the assessment of preterm delivery in
cardiovascular risk assessment in women. ( J Am Heart Assoc. 2018;7:e007809. DOI: 10.1161/JAHA.117.007809.)
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G lobally, preterm birth affects 11% of all pregnancies,with an estimated 14.9 million babies born before
37 weeks gestational age each year.1 In addition to being the
leading cause of neonatal mortality,2 there is increasing
evidence to show that preterm delivery is an adverse
pregnancy outcome associated with an increased risk of
future maternal cardiovascular health.3–5 Cardiovascular dis-
ease is the leading cause of mortality worldwide,6 most of
which is preventable by altering behavioral risk proﬁles and
lifestyle modiﬁcations, but there may be sex-speciﬁc cardio-
vascular risk factors that need to be recognized in women.7
Pregnancy is characterized by a challenge to the cardio-
vascular system with a doubling of blood volume, elevated
coagulation and inﬂammatory factors, hyperlipidemia, and
insulin resistance.8,9 This physiological stress for most women
is uncomplicated but for women who experience preterm birth,
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this adverse pregnancy outcome may serve to identify women
at risk for cardiovascular disease who would not have been
detected using traditional risk assessment tools at a time
when it may be possible to alter their risk trajectory.10–12
It remains unclear whether preterm delivery is an indepen-
dent risk factor for future cardiovascular disease or an early
marker of women with background high-risk proﬁles for future
cardiovascular disease. As preterm birth is a heterogeneous
condition with multiple causes, the pathogenesis of preterm
birth remains poorly understood. The main proposed mecha-
nisms include increased systemic inﬂammation, infection, or
vascular diseases.13–15 The duration of pregnancy gestation has
been inversely correlated to insulin resistance, blood pressure,
and low-grade inﬂammation in women years after delivery.16–18
In addition, women with previous preterm births, but without
pre-eclampsia or small-for-gestational-age births, have higher
atherogenic lipids and carotid arterial wall thickening in the
decade after delivery compared with women who had term
births.19 Therefore, the dysregulation in cardiometabolic factors
with their common pathways to cardiovascular diseases may
provide a possible explanation for the link between preterm
birth and future cardiovascular diseases.20,21
Previous studies, including a meta-analysis, have examined
the relationship between preterm delivery and future incident
cardiovascular disease.3–5 The previous meta-analysis included
studies published up to 2011.3 Since then, there have been
further studies including large sample sizes (ie, >100 000
participants).22–24 Some newer studies also demonstrated
results inconsistent with earlier literature showing no increased
risk for future stroke events.25,26 Furthermore, previous work
did not differentiate between morbidity and mortality out-
comes, nor examined clinically relevant factors such as
gestation at delivery, recurrence and cause of preterm births.
As recent guidelines from the United States27,28 and European
Union29 recommend the inclusion of a history of preterm birth
to evaluate the cardiovascular disease and stroke risk in women
based on evidence from cohort studies published up to
2011,30–35 there is a need for contemporary evidence. To this
end, we conducted a systematic review and meta-analysis to
quantify the risk of maternal cardiovascular events in later life
following preterm birth and contribute to future recommenda-
tions for clinical practice.
Methods
Eligibility Criteria
The data, analytic methods, and study materials have been
made available to other researchers for purposes of reproduc-
ing the results or replicating the procedure. The protocol was
registered on PROSPERO an International prospective register
of systematic reviews.36 We selected studies investigating
postnatal cardiovascular outcomes of women with preterm
delivery. Preterm delivery was deﬁned as birth any time before
37 weeks gestation. Primary cardiovascular outcomes were
composite cardiovascular disease (deﬁned as a combination of
cardiac, cerebrovascular, and peripheral vascular disease),
death caused by composite cardiovascular disease, coronary
heart disease, death caused by coronary heart disease, stroke,
and stroke death. The International Classiﬁcation of Diseases
(ICD) (versions 7-10) code deﬁnitions of the outcomes are
speciﬁc to each study and are detailed in Table S2. The included
studies had at least 2 groups (1 with preterm birth and 1 with
term birth) and reported sufﬁcient data to allow for accurate
risk estimates to be calculated. There was no restriction based
on language, cohort type, study design, or duration of follow-up.
Data Sources and Searches
MEDLINE andEMBASEwere searchedusingOVIDSP for studies
from inception to October 2017. The detailed search terms are
outlined inMethods S2.Manual searching for additional articles
was also conducted by reviewing the bibliography of relevant
review articles and published systematic reviews.3–5,37
Study Selection and Data Extraction
Two reviewers (P.W. and G.V.) screened all titles that met the
inclusion criteria. This was followed by a screen of the
remaining abstracts. The full articles were screened by
Clinical Perspective
What Is New?
• Preterm delivery is associated with a 1.4- to 2-fold increase
in maternal risk for future incident cardiovascular events,
cardiovascular death, coronary heart disease events, coro-
nary heart disease death, and stroke.
• This increased risk is greatest in preterm births that occur
before 32 weeks in gestation or in those that are delivered
for medical indications such as fetal growth restriction or
pre-eclampsia.
• For cardiovascular disease and coronary heart disease
outcomes, the risks are higher in women with a greater
number of recurrent preterm births.
What Are the Clinical Implications?
• In keeping with current recommendations, our study
highlights the importance of advising women with preterm
births about their increased cardiovascular risk and advo-
cating and supporting lifestyle and behavioral changes to
control their modiﬁable risk factors.
• These ﬁndings support the evaluation of preterm delivery in
cardiovascular risk assessment in postnatal women.
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the same 2 reviewers and the ﬁnal decision to include studies
was made by P.W. Independent double data extraction was
done by 4 reviewers (P.W., C.S.K., C.W., and A.N.). Data were
collected on study design, year, country, number of partici-
pants, mean age, parity, cohort characteristics, deﬁnition and
ascertainment of preterm birth, ascertainment of outcomes,
timing of assessment, adequacy of follow-up, and results. The
information was obtained from published data.
Study Quality Assessment
Study quality was assessed based on the recommendations of
the Newcastle-Ottawa Quality Assessment Scale for cohort
studies.38 We evaluated studies that had the following
characteristics as at low risk of bias: selection of exposed
cohort from the general population of pregnant women;
selection of nonexposed cohort from the same population;
reliable ascertainment of exposure such that the likelihood of
controls (term birth) being misclassiﬁed as having preterm
birth when they did not or cases being wrongly classiﬁed as
not having preterm birth was minimized; exclusion of women
who had cardiovascular outcome of interest before or during
pregnancy; comparable cohort where confounders, in partic-
ular age, pre-eclampsia, and diabetes mellitus/insulin resis-
tance, or any other cardiovascular risk factors such as
smoking, body mass index, and cholesterol, were accounted
for; assessment of outcomes prospectively or through linkage
of records and/or independent blind assessment; follow-up
duration for at least 5 years postpartum; and <10% of the
study participants in each cohort being lost to follow-up.
Data Synthesis and Analysis
We used RevMan Version 5.3.5 (Nordic Cochrane Centre) to
conduct random effects meta-analysis using the inverse
variance method for pooling log risk ratios (RRs). We used
random effects because the studies were conducted in a wide
range of settings in different populations, hence the need to
take heterogeneity into account for the pooled effect
estimate. Where possible, we chose to pool adjusted risk
estimates from primary studies and when these data were not
available, raw data were used to calculate unadjusted risk
estimates. Studies were pooled in meta-analysis with sub-
groups based on whether or not the study used adjustments
to account for confounders. Statistical heterogeneity was
assessed using the I2 statistic where I2 values of 30% to 60%
represented moderate level of heterogeneity.39 Where there
was greater than a moderate degree of heterogeneity, we
performed leave-1-out analysis to identify studies that con-
tributed to high degree of heterogeneity. In the case of an
analysis where there are more than 10 studies and little
evidence of heterogeneity, we planned to perform funnel plots
to assess for publication bias.40 Sensitivity analysis was
performed to consider the follow-up duration of the studies
(<10, 10–30, and >30 years), gestation (<32 weeks versus
32–37 weeks), and recurrence (1 recurrence versus ≥2
recurrence) of preterm births, and whether the preterm births
occurred spontaneously or were medically indicated. For the
sensitivity analysis on gestation, we excluded studies where
the subgroups could not be categorized as either <32 weeks
or 32 to 37 weeks gestation (eg, <34 weeks gestation).
Results
Description of Studies Included in Analysis
The initial MEDLINE and EMBASE search produced 653 titles
and abstracts. After screening, 21 studies were included in
the analysis (Figure 1) including 5 813 682 women in total
(ranges from 446 to 923 686 women in each study). Studies
recruiting patients from the same population were paired to
avoid duplication of participant numbers.31,32,41,42 Some
studies assessed the same population over different time
points.24,31,32,41–45 In these cases, the study with the longest
follow-up period was used for analysis in order to obtain the
highest event rate.
Table 1 summarizes the study designs and participant
characteristics. Out of the 16 studies that reported the
number of women in study and control groups, 338 007
women delivered preterm while 5 261 933 delivered at
term.* Data for women with singleton pregnancies were
included in 15 studies.† At the index pregnancy, the
participants had a mean or median age ranging from 23 to
31 years. The mean follow-up period ranged from 5.2 to
57 years.
Quality Assessment of Included Studies
The study quality was evaluated based on the recommenda-
tions of the Newcastle-Ottawa Quality Assessment Scale
(Tables S1 and S2).38 Fifteen studies were found to use
reliable methods for ascertaining the preterm birth exposure,
whereas 16 studies used reliable methods of obtaining
cardiovascular outcomes.
Pooled Analysis of Preterm Birth and
Cardiovascular Outcomes
Table 2 shows the results of the studies. A total of 8 studies
were pooled and showed a 1.6-fold signiﬁcantly increased
*References 5, 22, 23, 25, 26, 30, 31, 41, 43–51.
†References 22–24, 30–32, 35, 41–44, 47–50.
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maternal risk of composite cardiovascular disease in preterm
birth (RR 1.56, 95% conﬁdence interval [CI], 1.32, 1.84,
I2=93%) (Figure 2A).22,23,25,30,43,46,48,51 Combining the 5
studies that adjusted for potential confounders,23,25,43,46,48
the risk was 1.4-fold (adjusted risk ratio [aRR] 1.43, 95% CI,
1.18, 1.72; I2=89%). The potential confounding factors
evaluated in the studies are shown in Table S2. All 5 studies
had adjusted for age. We performed leave-1-out analyses to
explore the sources of heterogeneity. It was mainly driven by
the Catov 2010 study.43 By excluding this study, heterogene-
ity was reduced to 54% in the adjusted analysis (aRR 1.52,
95% CI, 1.31, 1.75). For composite cardiovascular disease
death, the pooled results suggest a 1.8-fold increase in
maternal cardiovascular disease death with preterm birth (RR
1.81, 95% CI, 1.55, 2.10, I2=70%; aRR 1.78, 95% CI, 1.42,
2.21, I2=77%) (Figure 2B).24,31,35,41,43,53 There were no com-
mon confounders in the adjusted studies as they had adjusted
for different confounding factors. The heterogeneity was
mainly driven by the Davey-Smith 2005 study.53 After
excluding this study, heterogeneity reduced to 0% in both
overall and adjusted analyses.
For coronary heart disease there was a 1.5-fold increase
risk of events with preterm birth (RR 1.50, 95% CI, 1.39, 1.62,
I2=51%, aRR 1.49, 95% CI, 1.38, 1.60, I2=54%) (Figure 3A). All
of the 5 studies that used adjusted data had adjusted for age
and socioeconomic status or education.23,25,43,44,50 The
heterogeneity was mainly driven by the Hastie 2011 study.44
If this study was excluded, heterogeneity was reduced to 33%
in the adjusted analysis (aRR 1.45, 95% CI, 1.33, 1.57). The 4
adjusted studies reporting coronary heart disease death
showed a 2-fold increased risk with preterm birth (aRR 2.10,
95% CI, 1.87, 2.36, I2=0%, Figure 3B).24,44,47,53 There were no
common confounders over these 4 studies as they had
adjusted for different confounding factors.
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and MEDLINE database searching 
between inception to October 2017
(N = 653).
Full-text articles excluded (N = 17).
Did not report outcomes of interest 
(N = 5).
Duplicate publication on the same 
study (N=4).
Study cohort with baseline vascular 
disease (N = 1).
Study compared pre-eclampsia 
group to no pre-eclampsia group 
(N=1).
Unable to calculate risk ratio 
reported (N=6).
Full-text articles assessed for 
eligibility (N = 36).
Title and abstract screened for 
potential inclusion (N = 653).
Records excluded which did not meet 
the inclusion criteria on reviewing the 
titles and abstracts (N = 617).
Studies included after full review of 
studies (N = 19).
Full text articles included from citations 
of reviews and meta-analyses (N = 2).
Total number of studies included in 
systematic review (N = 21).
Figure 1. Flow diagram of study inclusion. Adapted from: Moher et al.52
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Table 1. Study Design and Participant Characteristics
Study ID Study Design, Country, Year
Total No. of Participants
(Preterm/Term)
Mean Age at
Pregnancy (y) Parity Participant Selection Criteria
Bonamy 201130 Retrospective cohort study,
Sweden, 1983–2005
923 686 (preterm
56 893/term
866 793)
Median 26.9 P Women with a first singleton birth in
Sweden between 1983 and 2005
Catov 200746 Cross-sectional study,
United States, 1997–2004
446 (preterm 27/term
419)
23.5 P Women enrolled in the Health, Aging and
Body Composition (Health ABC) study on
70- to 79-year-olds living in Pittsburgh
during 1997 and 1998, who provided
their past obstetric history
Catov 201043 Retrospective cohort study,
Denmark, 1973–2006
427 765 (preterm
26 588/term
401 177)
25.5 A Women with singleton births in Denmark
between 1973 and 1983
Cirillo 201547 Prospective cohort study,
United States, 1959–2011
10 310 (preterm
1251/term 9059)
Median 26 A Women receiving prenatal care from the
Kaiser Health Plan in California recruited
to the Child Health and Development
Studies (CHDS)
Smith 200035 Cohort study, Finland, 1954
–2000
3706 Unclear P A cohort of singleton live births between
1954 and 1963 in Helsinki
Smith 200553 Cohort study, Finland, 1973
–1997
10 368 mothers and
22 807 fathers
Unclear A Parents who had children born between
1973 and 1980 in Sweden
Freibert 201151 Cross-sectional study,
United States, 2006–2008
2882 (preterm 324/
term 2558)
Unclear A Women from the Kentucky Women’s
Health Registry aged ≥50 y of age
between 2006 and 2008, who provided
their past obstetric history
Hastie 201144 Retrospective cohort study,
Scotland, 1969–2007
750 350 (preterm
44 743/term
705 607)
Median 24.5 P Women with first singleton live births in
Scotland between January 1969 and
July 2007
Hovi 201422 Retrospective cohort study,
Finland, 1987–2012
152 219 mothers
(preterm 8720/term
39–41 wks
143 499) and
190 996 fathers
Unclear P Women with first singleton births in the
Finnish Medical Birth Register from
1987 to 1990
Irgens 200145 Retrospective cohort study,
Norway, 1967–1992
602 117 (preterm
26 018/term
576 099)
Unclear P Women with first deliveries recorded in
the Norwegian medical birth registry
from 1967 to 1992
Kessous 201348 Retrospective cohort study,
Israel, 1988–2010
47 908 (preterm
5992/term 41 916)
29 A Women with singleton birth at the Soroka
University Medical Center in Negev
between 1988 and 1999
Lykke 201041 &
Lykke 201031
Retrospective cohort study,
Denmark, 1978–2007
755 398 (preterm
41 659/term
713 739) in Lykke
201041 or 685 594
(preterm 41 659/
term 643 935) in
Lykke 201031
26.8 P Women with first singleton delivery in
Denmark from 1978 to 2007
Nardi 200649 Case–control study, France,
1990–2000
514 (preterm 76/term
438)
55 at enrollment P Women born between 1925 and 1950
who had a first MI between 1990 and
2000, matched with women of similar
age, year and month of inclusion in
study, educational level and area of
residence. All women were in a health
insurance scheme primarily covering
teachers who had singleton pregnancies
Continued
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Figure 4 shows the pooled analysis for studies on maternal
preterm birth and stroke, and illustrate the risk to be
increased by 1.7-fold in preterm birth (aRR 1.65, 95% CI,
1.51, 1.79, I2=0%).23,25,26,32,42,43 All studies had adjusted for
potential confounders that included age and socioeconomic
status or education or urbanization level. The pooled result on
preterm birth and stroke death was not statistically signiﬁcant
(aRR 1.30, 95% CI, 0.94, 1.80, I2=66%).24,53 We did not
perform funnel plots to assess for publication bias as <10
studies were included in each analysis.
Sensitivity Analysis for Follow-Up Time
We conducted sensitivity analyses to consider the effect of
follow-up time for cardiovascular outcomes that were signif-
icant in the adjusted studies (Table 3). At <10 years following
preterm birth, the risks for composite cardiovascular disease
(RR 1.65, 95% CI, 1.49, 1.82), coronary heart disease (RR
1.61, 95% CI, 1.40, 1.86), and stroke (RR 1.67, 95% CI, 1.45,
1.93) were already signiﬁcant and similar to longer follow-up
times.
Sensitivity Analysis Considering Effect of
Gestation of Preterm Birth, Recurrence of
Preterm Birth, and Spontaneous Versus Medically
Indicated Preterm Birth
Sensitivity analyses were performed to consider the effect of
gestation, recurrence, and spontaneous onset of preterm birth
in the 5 cardiovascular outcomes that were signiﬁcant in the
adjusted studies. These showed that the risks were higher
when preterm deliveries occurred before 32 weeks gestation in
all outcomes: composite cardiovascular disease (RR 1.85, 95%
CI, 1.51, 2.28), composite cardiovascular disease death (RR
2.10, 95% CI, 1.61, 2.74), coronary heart disease (RR 1.62, 95%
CI, 1.28, 2.04), coronary heart disease death (RR 2.30, 95% CI,
1.53, 3.46), and stroke (RR 2.00, 95% CI, 1.65, 2.43), compared
with those occurring at 32 to 37 weeks gestation (Table 4).
When recurrence of preterm birth was studied, the risks for
composite cardiovascular disease (RR 1.58, 95% CI, 1.17,
2.12) and coronary heart disease (RR 1.95, 95% CI, 1.53,
2.50) were higher if the preterm birth recurred in 2 or more
pregnancies compared with recurring once only (Table 5). The
Table 1. Continued
Study ID Study Design, Country, Year
Total No. of Participants
(Preterm/Term)
Mean Age at
Pregnancy (y) Parity Participant Selection Criteria
Ngo 201523 Retrospective cohort study,
Australia, 1994–2012
797 056 (preterm
59 563/term
737 493)
Median 31 A Women who had a singleton birth
between July 1994 and December 2011
in New South Wales
Pell 200442 &
Smith 200132
Retrospective cohort study,
Scotland, 1981–1999
199 668 (Pell 2004)
or 129 920 (Smith
2001)
Median 23 P Women with first singleton live births in
Scotland between 1981 and 1985
Rich-Edwards 201524 Retrospective cohort study,
Norway, 1967–2009
688 662 (preterm
40 981
[spontaneous
33 230; indicated
7751]/term
647 681
[spontaneous
550 604; indicated
97 077])
24.6 P Women with first singleton birth between
1967 and 1998 in the Medical Birth
Registry of Norway
Tanz 201725 Prospective cohort study,
United States, 1989–2013
70 182 (preterm
6178, term 64 004)
27.4 P Subset of women with pregnancies in the
Nurses’ Health Study II, that followed
registered nurses aged 25 to 42 y in 1989
Wang 201126 Retrospective cohort study,
Taiwan, 2000–2008
4715 (preterm 1134/
term 3581)
27.8 P Randomly selected, frequency-matched
control women delivering in the same
year as women with hypertensive
disorders in pregnancy in the National
Health Insurance program between 2000
and 2004
Wikstrom 200550 Cross-sectional study;
Sweden; 1973–1982
365 730 (preterm
17 860/term
347 870)
Median 48* P Women in the Swedish Medical Birth
Register from 1973 to 1982 with
singleton pregnancies
A indicates any parity; MI, myocardial infarction; P, primiparous.
*Age at follow-up.
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Table 2. Study Outcomes, Follow-Up and Results
Study ID Deﬁnition of Preterm
Follow-Up
Duration Deﬁnition of Outcome Results (Preterm vs Term)
Bonamy 201130 Moderately preterm (32–
36 wks), very preterm
(28–31 wks),
extremely preterm
(≤27 wks)
11.8 y CVD: unstable angina, acute
MI, cerebral infarction,
cerebral hemorrhage,
subarachnoid hemorrhage,
transient ischemic attack,
acute stroke or heart
failure
32 to 36 wks: 320/49 537 vs 3154/866 793.
aHR 1.39 (1.22–1.58)
28 to 31 wks: 70/5259 vs 3154/866 793.
aHR 2.57 (1.97–3.34)
≤27 wks: 24/2097 vs 3154/866 793.
aHR 2.18 (1.33–3.57)
Catov 200746 Delivery <37 wks
gestation
57 y CVD: MI, angina, coronary
artery bypass surgery,
percutaneous transluminal
angioplasty, stroke or
peripheral vascular disease
12/27 vs 120/491. aHR 2.85 (1.19–6.85)
Catov 201043 Delivery <37 wks
gestation
28 y CVD: CHD, stroke,
hypertension,
atherosclerosis or
thrombosis
Any preterm: 3454/26 588 vs 39 485/
401 177. aHR 1.18 (1.10–1.25)
35 to 36 wks: aHR 1.26 (1.20–1.33)
33 to 34 wks: aHR 1.26 (1.16–1.37)
≤32 wks: aHR 1.36 (1.21–1.53)
Recurrent 1 preterm birth: aHR 1.16 (1.09–
1.25)
Recurrent ≥2 preterm births:
aHR 1.26 (1.05–1.51)
CVD death* Any preterm: aHR 1.98 (1.73–2.26)
35 to 36 wks: aHR 1.87 (1.59–2.14)
33 to 34 wks: aHR 2.10 (1.73–2.78)
≤32 wks: aHR 2.10 (1.47–3.00)
Recurrent 1 preterm birth:
aHR 1.70 (1.33–2.16)
Recurrent ≥2 preterm births:
aHR 2.12 (1.22–3.68)
CHD* Any preterm: 1272/26 588 vs 13 283/
401 177. aHR 1.42 (1.34–1.52)
35 to 36 wks: aHR 1.41 (1.30–1.53)
33 to 34 wks: aHR 1.49 (1.32–1.68)
≤32 wks: aHR 1.38 (1.15–1.66)
Recurrent 1 preterm birth:
aHR 1.22 (1.09–1.36)
Recurrent ≥2 preterm births:
aHR 1.78 (1.40–2.27)
Stroke* Any preterm: 351/26 588 vs 3185/401 177.
aHR 1.67 (1.48–1.89)
35 to 36 wks: aHR 1.73 (1.49–2.01)
33 to 34 wks: aHR 1.42 (1.10–1.84)
≤32 wks: aHR 1.92 (1.38–2.67)
Recurrent 1 preterm birth:
aHR 1.77 (1.44–2.17)
Recurrent ≥2 preterm births:
aHR 1.37 (0.75–2.49)
Cirillo 201547 Delivery <37 wks
gestation
40 y CHD death aHR 2.1 (1.40–3.01)
Smith 200035 Delivery <37 wks
gestation
Unclear CVD death aHR 2.06 (1.22–3.47)
Smith 200553 Delivery <37 wks
gestation
20.4 y CVD (CHD and stroke) death aHR 1.32 (1.09–1.61)
CHD death aHR 1.66 (1.20–2.29)
Stroke death aHR 1.07 (0.77–1.49)
Continued
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Table 2. Continued
Study ID Deﬁnition of Preterm
Follow-Up
Duration Deﬁnition of Outcome Results (Preterm vs Term)
Freibert 201151 Delivery between 20 and
36 wks gestation
Unclear CVD 110/324 vs 573/2558
CHD 37/324 vs 159/2558
Hastie 201144 Delivery <37 wks
gestation
22 y CHD Any preterm: aHR 1.58 (1.47–1.71)
Spontaneous (n=29 965):
aHR 1.46 (1.33–1.61)
Medically indicated (n=14 747):
aHR 1.81 (1.61–2.04)
CHD death Any preterm: aHR 2.26 (1.88–2.71)
Spontaneous (n=29 965):
aHR 2.14 (1.70–2.70)
Medically indicated (n=14 747):
aHR 2.49 (1.89–3.30)
Hovi 201422 Delivery <37 wks
gestation
22 y CVD: CHD and stroke Any preterm: 431/8720 vs 4127/143 499
34 to 36 wks: 303/6540 vs 4127/143 499.
HR 1.55 (1.38–1.74)
32 to 33 wks: 50/954 vs 4127/143 499. HR
1.61 (1.22–2.13)
28 to 31 wks: 52/809 vs 4127/143 499. HR
2.12 (1.61–2.79)
<28 wks: 26/417 vs 4127/143 499. HR 2.00
(1.36–2.94)
Irgens 200145 Delivery between 16 and
36 wks gestation
13 y CHD death aHR 2.95 (2.12–4.11)
Stroke death aHR 1.91 (1.26–2.91)
Kessous 201348 Delivery <37 wks
gestation
10 y CVD: hospitalization for CHD,
stroke, peripheral vascular
disease, hyperlipidemia,
angina, hypertension,
atherosclerosis, MI, heart
failure, pulmonary heart
disease, cardiac arrest,
cardiac catheterization or
cardiovascular stress test
Any preterm: aHR 1.4 (1.2–1.6)
34 to 37 wks (n=4596): OR 1.4 (1.2–1.6).
<34 wks (n=1396): OR 1.7 (1.3–2.1)
Spontaneous (n=41 669): OR 1.4 (1.2–1.6)
Medically indicated (n=6239):
OR 1.7 (1.3–2.4)
Recurrent 1 preterm birth: 261/5217
vs 1467/41 916
Recurrent ≥2 preterm births: 43/775
vs 1467/41 916
Lykke 2010a41 &
Lykke 2010b31
Delivery <37 wks
gestation
14.6 y (Lykke
2010a)
CHD Any preterm: 589/41 659 vs 7257/713 739
32 to 36 wks: 500/35 255 vs 7257/713 739.
aHR 1.32 (1.20–1.45)
28 to 31 wks: 63/4698 vs 7257/713 739.
aHR 1.03 (0.80–1.34)
20 to 27 wks: 26/1706 vs 7257/713 739.
aHR 1.61 (1.09–2.37)
Recurrent 1 preterm birth: 71/4244 vs 4730/
471 052. aHR 1.36 (1.02–1.81)
14.8 y (Lykke
2010b)
CVD (CHD, stroke,
hypertension,
thromboembolic disease
and type 2 diabetes
mellitus) death
115/41 659 vs 824/643 935.
aHR 1.98 (1.64–2.40)
Nardi 200649 Delivery <8 mo
gestation
5.2 y CHD death 23/76 vs 86/438
Ngo 201523 Delivery 20 to 36 wks
gestation
7.5 y CVD: hospitalization or death
for CHD, stroke, and
congestive heart failure
Any preterm: aHR 1.65 (1.50–1.83)
35 to 36 wks: aHR 1.53 (1.35–1.74)
33 to 34 wks: aHR 1.89 (1.55–2.31)
20 to 32 wks: aHR 1.83 (1.50–2.23)
Continued
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Table 2. Continued
Study ID Deﬁnition of Preterm
Follow-Up
Duration Deﬁnition of Outcome Results (Preterm vs Term)
Spontaneous: aHR 1.53 (1.35–1.72)
Medically indicated: aHR 1.93 (1.66–2.25)
1 preterm birth: aHR 1.62 (1.46–1.79).
Recurrent ≥2 preterm births:
aHR 2.04 (1.56–2.67)
CHD Any preterm: aHR 1.61 (1.39–1.85)
35 to 36 wks: aHR 1.49 (1.24–1.78)
33 to 34 wks: aHR 1.89 (1.43–2.51)
20 to 32 wks: aHR 1.72 (1.29–2.29)
Spontaneous: aHR 1.53 (1.29–1.81)
Medically indicated: aHR 1.77 (1.41–2.21)
1 preterm birth: aHR 1.54 (1.33–1.79)
Recurrent ≥2 preterm births:
aHR 2.31 (1.61–3.33)
Stroke Any preterm: aHR 1.68 (1.46–1.95)
35 to 36 wks: aHR 1.49 (1.23–1.80)
33 to 34 wks: aHR 1.90 (1.41–2.56)
20 to 32 wks: aHR 2.13 (1.61–2.82)
Spontaneous: aHR 1.49 (1.24–1.78)
Medically indicated: aHR 2.12 (1.70–2.65)
1 preterm birth: aHR 1.68 (1.44–1.95)
Recurrent ≥2 preterm births:
aHR 1.76 (1.14–2.73)
Pell 200442 & Smith
200132
Delivery 24 to 36 wks
gestation
14 to 19 y (Pell
2004)
Stroke aHR 1.91 (1.35–2.70).
15 to 19 y
(Smith 2001)
CHD death HR 2.2 (0/9–5.7). aHR 1.9 (0.7–4.9)
Rich-Edwards
201524
Delivery <37 w
gestation
24.8 y CVD (CHD and stroke) death HR 1.9 (1.7–2.2)
Spontaneous:
Any preterm: HR 1.7 (1.5–2.0)
35 to 36 wks: aHR 1.4 (1.0–1.8)
32 to 34 wks: aHR 1.9 (1.3–2.7)
22 to 31 wks: aHR 2.1 (1.4–3.1)
Medically indicated:
Any preterm: HR 3.7 (2.4–4.5)
Recurrent 1 preterm birth: aHR 3.3 (2.4–4.5)
CHD death Spontaneous:
Any preterm: aHR 2.1 (1.7–2.5)
35 to 36 wks: aHR 2.1 (1.6–2.7)
32 to 34 wks: aHR 2.4 (1.7–3.4)
22 to 31 wks: aHR 2.3 (1.5–3.4)
Medically indicated:
35 to 36 wks: aHR 6.2 (4.2–9.3)
32 to 34 wks: aHR 3.4 (1.7–6.9)
22 to 31 wks: aHR 4.7 (2.2–9.8)
Stroke death Spontaneous:
Any preterm: 1.5 (1.2–1.8)
35 to 36 wks: aHR 1.3 (0.9–1.7)
32 to 34 wks: aHR 1.9 (1.3–2.8)
22 to 31 wks: aHR 1.8 (1.1–2.8)
Medically indicated:
Any preterm: aHR 3.0 (2.0–4.3)
35 to 36 wks: aHR 2.9 (1.7–5.1)
32 to 34 wks: aHR 1.9 (0.8–4.7)
22 to 31 wks: aHR 5.4 (2.8–10.4)
Continued
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risks for all available outcomes were greatest when the
preterm birth occurred as a result of medically indicated
compared with spontaneous preterm birth: composite cardio-
vascular disease (RR 1.88, 95% CI, 1.64, 2.16), composite
cardiovascular disease death (RR 3.70, 95% CI, 2.88, 4.76),
coronary heart disease (RR 1.80, 95% CI, 1.62, 2.00),
coronary heart disease death (RR 3.56, 95% CI, 1.74, 7.25),
and stroke (RR 2.12, 95% CI, 1.70, 2.65, Table 6).
The full cardiovascular risk factor proﬁle of the preterm birth
and the control term birth population is described in Table S3.
Signiﬁcant differences in age,44,48 ethnicity,48 education,43
socioeconomic class,44 obesity,48 hypertension,44 pre-eclamp-
sia,43,44 and small-for-gestational-age fetus43 between the
preterm and term birth groups were detected at the index
pregnancy in 3 studies. Although these only contributed to 21%
of total participant women, the cardiovascular risk factor
proﬁles at the index birth were not available in the majority of
participants within this systematic review and meta-analysis.
Additional sensitivity analyses were performed where studies
were stratiﬁed by singleton pregnancies, year of the study,
quality of the study, location of the study, and pre-existing
cardiovascular diagnosis in participants (Tables S4 through S8).
We found that the results did not vary substantially.
Discussion
This meta-analysis examined 96 341 474 women years and
included 338 007 women with preterm birth out of
5 813 682 study participants in 21 studies. We found that
preterm delivery is associated with an increased maternal
risk for future incident cardiovascular events, cardiovascular
death, coronary heart disease events, coronary heart disease
death, and stroke. The adjusted risk ranged between 1.4-
and 2-fold compared with those without a history of preterm
birth. This increased risk is greatest in preterm births that
occur before 32 weeks in gestation or in those that are
delivered for medical indications such as fetal growth
restriction or pre-eclampsia. For the composite cardiovascu-
lar disease and coronary heart disease outcomes, the risks
are higher in women with a greater number of recurrent
preterm births. Preterm delivery is a signiﬁcant event in a
woman’s reproductive history with a good recall rate
including high speciﬁcity.54–56 Therefore, it may be consid-
ered as a potential risk factor for future cardiovascular
disease in women, as recommended by the current guide-
lines from the American Heart Association and European
Society of Cardiology.27–29
By including an additional 1.7 million participants to the
previous meta-analysis in this ﬁeld, our results are consistent
with earlier literature showing an increased risk in coronary
heart disease, stroke, and composite cardiovascular disease.3
Although our risk estimate for composite cardiovascular
disease was lower than previously reported, this may be
because of the difference in data analysis. In the previous
meta-analysis, there was no distinction between adjusted and
unadjusted data nor between morbidity and mortality out-
comes. There are 2 other systematic reviews without meta-
analysis of the literature, which also support our ﬁndings.4,5
Unique to this study, we conducted sensitivity analyses to
consider the duration of follow-up, gestation at birth,
Table 2. Continued
Study ID Deﬁnition of Preterm
Follow-Up
Duration Deﬁnition of Outcome Results (Preterm vs Term)
Tanz 201725 Delivery >20 and
<37 wks gestation
32 y CVD: MI and stroke Without hypertensive disorders of pregnancy
(preterm 4487 vs term 51 343):
Any preterm: aHR 1.35 (1.06–1.72)
32 to <37 wks: aHR 1.12 (0.83–1.52)
20 to <32 wks: aHR 2.01 (1.38–2.93)
Recurrent 1 preterm birth:
aHR 1.63 (1.18–2.25)
CHD Any preterm: aHR 1.55 (1.19–2.01)
32 to <37 wks: aHR 1.36 (0.99–1.86)
20 to <32 wks: aHR 2.10 (1.38–3.21)
Stroke Any preterm: aHR 1.28 (0.95–1.71)
32 to <37 wks: aHR 1.09 (0.76–1.56)
20 to <32 wks: aHR 1.84 (1.15–2.95)
Wang 201126 Unclear 6.4 y Stroke aHR 1.51 (0.77–2.93)
Wikstrom 200550 Delivery <37 wks
gestation
15 y CHD 145/17 860 vs 1959/347 870.
aRR 1.3 (1.1–1.5)
Data are HR/OR (95% conﬁdence intervals). aHR indicates adjusted hazard ratio; aRR, adjusted risk ratio; CHD, coronary heart disease/ischemic heart disease; CVD, cardiovascular
disease; MI, myocardial infarction; RR, risk ratio.
*Data not adjusted for diabetes mellitus.
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recurrent preterm birth, and spontaneous or medically
indicated preterm birth.
Because of the multifactorial nature of preterm birth
causes, several pathognomonic mechanisms have been
hypothesized.13,57 These include vascular and metabolic
factors,58–60 as well as pre-eclampsia and fetal growth
restriction that have both been independently associated
with future adverse cardiovascular outcomes.61–63 Moreover,
preterm birth markers, such as proinﬂammatory cytokines,
matrix metalloproteinase, ﬁbrinolysis, prostaglandin
cascade,8,59,64–68 and dyslipidemia,59,66,69 are also involved
in atherosclerosis and endothelial dysfunction.34,70–73
Figure 2. Risk of composite cardiovascular disease with preterm birth. A, Cardiovascular disease events. B, Cardiovascular disease death.
CI indicates conﬁdence interval.
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Therefore, preterm birth shares common risk factors with
cardiovascular disease74,75 and the association we identiﬁed
may have been an epiphenomenon in women with high
cardiovascular risk proﬁles that predispose them to both
preterm birth and cardiovascular diseases. In contrast, other
longitudinal studies have shown no difference in lipid proﬁle,
blood pressure, and inﬂammatory markers between preterm
and term deliveries.17,76
There may also be other possible hypotheses for the
association of preterm delivery and long-term adverse
cardiovascular outcomes. One third of normotensive preterm
births exhibit placental abnormalities commonly seen in pre-
eclampsia and placental insufﬁciency,77,78 while 17% of
preterm births are medically indicated.79 Common medical
indications for preterm birth include pre-eclampsia and
placental insufﬁciency causing fetal growth restriction, which
Figure 3. Risk of coronary heart disease with preterm birth. A, Coronary heart disease events. B, Coronary heart disease death. CI
indicates conﬁdence interval.
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may have confounded any relationships reported in the
literature. Moreover, diabetes mellitus is more common in
women with previous preterm deliveries, which may have
confounded our ﬁndings.80 Although smoking has not been
universally agreed upon as a risk factor for preterm birth,81,82
the causative relationship between smoking and cardiovas-
cular diseases is well established.83–86 Other possible
confounders include obesity and socioeconomic status, both
of which have been linked to increased risks of preterm
birth32,87–89 and cardiovascular disease in women.90–92
Although the majority of the included studies (n=16) have
attempted to adjust for some potential confounders,‡ none of
the studies have adequately adjusted for all relevant risk
factors that form the basis of many of the established
cardiovascular risk prediction scores (eg, cholesterol and
family history of cardiovascular disease). There was also
limited overlap between the adjusted confounding factors
among the studies. As many key confounders for cardiovas-
cular diseases were not adjusted for in the included studies, it
is possible that the relationships that we have reported are
entirely driven by differences in cardiovascular risk factor
proﬁles at baseline. In the studies (48% of total participants)
that presented the baseline cardiovascular risk factor proﬁles,
the majority did not calculate whether there were any
differences between the preterm and term birth groups. In
the 3 studies (21% of total participants) that calculated this
difference, all of them showed signiﬁcant baseline risk factor
proﬁle differences between the preterm birth and the term
birth populations.43,44,48
The 2011 American Heart Association guidelines for
cardiovascular disease prevention in women advised health-
care professionals to inquire about adverse pregnancy
outcomes, including preterm delivery, as a part of any
cardiovascular risk assessment in women. However, there
was a lack of additional speciﬁc guidance as preterm birth
was not considered a major cardiovascular disease risk
factor.28 The 2014 guidelines from the American Heart
Association and American Stroke Association for the preven-
tion of stroke in women also recognized preterm birth as a
factor associated with increased stroke risks after pregnancy,
but did not make further recommendations because of the
lack of evidence in the literature.27 More recently, the 2016
European Society of Cardiology guidelines recommended the
consideration of periodic screening for hypertension and
Figure 4. Risk of stroke with preterm birth. CI indicates conﬁdence interval.
Table 3. Sensitivity Analyses With Regard to Duration of
Follow-Up
Outcomes <10 Y 10 to 30 Y >30 Y
CVD 1.65 [1.49, 1.82],
n=1
1.54 [1.19, 2.01],
n=4
1.73 [0.87, 3.46],
n=2
CVD
death
 1.79 [1.51, 2.11],
n=4

CHD 1.61 [1.40, 1.86],
n=1
1.45 [1.32, 1.60],
n=3
1.55 [1.19, 2.01],
n=1
CHD
death
1.54 [1.04, 2.28],
n=1
2.08 [1.80, 2.40],
n=3
2.10 [1.43, 3.08],
n=1
Stroke 1.67 [1.45, 1.93],
n=2
1.70 [1.51, 1.90],
n=2
1.28 [0.95, 1.72],
n=1
Data are risk ratio [95% conﬁdence intervals], number of pooled studies. CHD indicates
coronary heart disease; CVD, cardiovascular disease.‡References 23–26, 30–32, 35, 41–48, 50, 53.
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diabetes mellitus in women with a history of preterm birth.29
In line with these recommendations, we suggest a detailed
evaluation of a screening program for cardiovascular disease
in women with a history of preterm birth, particularly in
women who delivered because of any medical indications or
before 32 weeks gestation (ie, the very or extremely preterm
as deﬁned by the World Health Organization). An opportune
time for this screening is at the 6-week postpartum visit
suggested in the World Health Organization recommendations
on postnatal care.93
The strength of our study lies in the large sample size with a
total of 96 341 474 patient-years follow-up. We used a search
strategy without limiting the study design, language, and used
independent reviewers for performing double data extractions
and data analysis. All of the studies were designed to assess
future cardiovascular diseases as their main outcome.
The limitations of this study include the risk of confounding
and being unable to attribute causality of future cardiovascu-
lar disease to preterm delivery. These are because of the
longitudinal nature of the epidemiological studies we included
in this meta-analysis. As with any meta-analysis, there may be
inherent publication bias, where studies with positive ﬁndings
are more likely to be published compared with those showing
neutral or negative outcomes. Over half of the included
studies were retrospective in design. Therefore, there was
limited control over the quality of data collected. As such, the
preterm birth exposure could have been prone to recall bias or
inaccuracies in historical data collection. Furthermore, the
cardiovascular outcomes were determined by subjective self-
reporting in 3 studies.25,46,51 Heterogeneity may have arisen
because of differences in the study population, research
methodology, period of conducting the study, and inherent
differences between the studies. Two studies were conducted
in ethnically diverse populations26,48 in contrast to the other
studies that were performed in white populations. Six studies
examined women of any parity,23,43,47,48,51,53 while the others
studied primiparous women. Speciﬁc populations were ana-
lyzed in 2 studies, which were Nardi et al49 (women covered
by a particular health insurance program) and Tanz et al25
(nurses). As shown in Table 1, there was a mixture of
retrospective, prospective, cross-sectional, and case–control
studies. Because of the variation in duration of follow-up in
the studies, the index preterm birth could have occurred in
1954 or in 2011. There has been both a change in obstetric
practice, cardiovascular screening, and management of
cardiovascular risk factors over these 57 years, which could
have contributed toward differences between the studies. In
the composite cardiovascular disease outcome, the hetero-
geneity was mainly driven by the Catov 2010 study.43 Out of
the pooled adjusted studies, this was the only study
conducted in Europe as the others were conducted in the
United States, Australia, or Israel.
Our ﬁnding of an association between preterm delivery and
the future development of incident cardiovascular disease has
important implications for women and health policy. Women
who experience a preterm delivery are at a higher risk of
cardiovascular events and this suggests that a formal
cardiovascular risk assessment using established risk scores
should be considered in these women.94,95 In addition,
clinicians may ﬁnd it pertinent to educate women regarding
their increased cardiovascular risk and potentially motivate
women toward controlling any modiﬁable risk factors. The
perinatal period is a valuable time for opportunistic advice,
education, intervention, and monitoring in at-risk women.
However, there is little awareness regarding the long-term
cardiovascular consequences of pregnancy complications
Table 4. Sensitivity Analysis With Regard to Gestation of
Preterm Birth
Outcomes <32 Wks 32 to 37 Wks
CVD 1.85 [1.51, 2.28], n=6 1.40 [1.23, 1.59], n=5
CVD death 2.10 [1.61, 2.74], n=2 1.85 [1.58, 2.16], n=2
CHD 1.62 [1.28, 2.04], n=3 1.44 [1.35, 1.53], n=3
CHD death 2.30 [1.53, 3.46], n=1 2.20 [1.78, 2.71], n=1
Stroke 2.00 [1.65, 2.43], n=3 1.49 [1.22, 1.83], n=3
Data are risk ratio [95% conﬁdence intervals], number of pooled studies. CHD indicates
coronary heart disease; CVD, cardiovascular disease.
Table 5. Sensitivity Analysis With Regard to Recurrence of
Preterm Birth
Outcomes Recurrent 1 Preterm Birth Recurrent ≥2 Preterm Births
CVD 1.42 [1.17, 1.73], n=4 1.58 [1.17, 2.12], n=3
CVD death 2.35 [1.23, 4.50], n=2 2.12 [1.22, 3.68], n=1
CHD 1.36 [1.09, 1.71], n=2 1.95 [1.53, 2.50], n=2
Stroke 1.77 [1.44, 2.17], n=1 1.61 [1.13, 2.30], n=2
Data are risk ratio [95% conﬁdence intervals], number of pooled studies. CHD indicates
coronary heart disease; CVD, cardiovascular disease.
Table 6. Sensitivity Analysis With Regard to Spontaneous or
Medically Indicated Preterm Birth
Outcomes Spontaneous Medically Indicated
CVD 1.47 [1.34, 1.62], n=2 1.88 [1.64, 2.16], n=2
CVD death 1.70 [1.47, 1.96], n=1 3.70 [2.88, 4.76], n=1
CHD 1.48 [1.36, 1.60], n=2 1.80 [1.62, 2.00], n=2
CHD death 2.12 [1.82, 2.45], n=2 3.56 [1.74, 7.25], n=2
Stroke 1.49 [1.24, 1.79], n=1 2.12 [1.70, 2.65], n=1
Data are risk ratio [95% conﬁdence intervals], number of pooled studies. CHD indicates
coronary heart disease; CVD, cardiovascular disease.
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among healthcare professionals. A survey showed that only
5% of internists inquired about pre-eclampsia during history
taking, while primary care data showed that 50% of women
who had pre-eclampsia did not receive any further postnatal
follow-up after 3 months.96,97 Cardiovascular disease
presents differently between men and women,28,98 and most
cardiac sudden deaths in women occur without prior
history of heart disease.99,100 Therefore, it would be appro-
priate to utilize past obstetric history to comprehensively
assess cardiovascular risk proﬁles in women. Our ﬁndings
support the current guidelines from the American Heart
Association27,28 and the European Society of Cardiology29 to
assess preterm delivery as part of the cardiovascular disease
risk assessment in women.
Conclusions
Our large meta-analysis that included 5 813 682 women,
338 007 of whom had experienced a preterm delivery,
demonstrated that preterm birth is associated with a 1.4- to
2-fold increase in future adverse cardiovascular outcomes. In
keeping with current recommendations, our study highlights
the importance of advising women with preterm births about
their increased cardiovascular risk and advocating and
supporting lifestyle and behavioral changes to control their
modiﬁable risk factors. These ﬁndings support the assess-
ment of preterm delivery in cardiovascular risk assessment in
women, with the 6-week postpartum visit the ideal place for
this to occur.
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Data S1.  
 
Search terms 
 
Synonyms of preterm birth (‘preterm delivery’ or ‘preterm birth’ or ‘premature delivery’ or 
‘premature birth’) AND ‘ischaemic heart disease’ or ‘ischemic heart disease’ or ‘coronary 
artery disease’ or ‘coronary heart disease’ or ‘myocardial infarction’ or ‘acute coronary 
syndrome’ or ‘heart failure’ or ‘cardiac failure’ or ‘left ventricular systolic dysfunction’ or 
‘stroke’ or ‘cerebrovascular disease’ or ‘cerebrovascular accident’ or ‘cardiomyopathy’ or 
‘peripheral vascular disease’ or ‘cardiovascular disease’ or ‘cardiovascular morbidity’ or 
‘cardiovascular mortality’. 
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Table S1. Study quality assessment overview. 
Study ID Representative 
of the exposed 
cohort 
Selection of 
the non-
exposed 
cohort 
Ascertainment 
of preterm 
birth 
Demonstration 
that outcome of 
interest was not 
present at start 
of study 
Comparability 
of cohort 
Assessment 
of outcome 
Follow-up 
duration to 
capture 
outcomes 
 
Adequacy 
of follow-up 
Total 
score  
Bonamy 20111 * * * * ** * * * 9 
Catov 20072 * * 
 
 ** 
 
* * 6 
Catov 20103 * * * * ** * * * 9 
Cirillo 20154 * * * * * * * * 8 
Davey Smith 
20005 
* * * * * *   6 
Davey Smith 
20056 
* * * * * * * 
 
7 
Freibert 20117 * *      * 3 
Hastie 20118 * * * 
 
* * * * 7 
Hovi 20149 * * *  
 
* * * 6 
Irgens 200110 * * * * * * * * 8 
Kessous 201311 * * * * ** * * * 9 
Lykke 2010a12 & 
Lykke 2010b13 
* * * * ** * * * 9 
Nardi 200614 
 
* 
 
* * * *  5 
Ngo 201515 * * * * * * * * 8 
Pell 200416 & 
Smith 200117 
* * * 
 
* * * 
 
6 
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Rich-Edwards 
201518 
* * * * * * * * 8 
Tanz 201719 
 
* 
 
* * 
 
* 
 
4 
Wang 201120 * * * * * * * * 8 
Wikstrom 200521 * * *  * * * * 7 
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Table S2. Study quality assessment in detail. 
Study ID Representative 
of the exposed 
cohort 
Selection 
of the 
non-
exposed 
cohort 
Ascertainment 
of preterm 
birth 
Demonstration 
that outcome of 
interest was not 
present at start of 
study 
Comparability of cohort Reliable 
ascertainment of 
outcomes 
Follow-up 
duration 
to capture 
outcomes 
 
Adequacy 
of follow-
up 
Bonamy 
20111 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
Swedish 
Medical Birth 
Register. 
Excluded women 
with a CVD event 
before their first 
delivery. 
Adjusted for maternal age, 
birth year, highest income and 
highest education level before 
first delivery, country of birth, 
pregestational hypertension, 
pregestational diabetes 
mellitus, gestational diabetes 
mellitus, gestational 
hypertension, pre-
eclampsia/eclampsia and 
maternal smoking at beginning 
of pregnancy. 
ICD-8 to 10 codes 
from the hospital 
discharge register or 
the cause of death 
register. 
 
ICD-8: 411, 427.00, 
427.10. 
ICD-9: 411B, 428. 
ICD-8/9: 410, 430-
436.  
ICD-10: G45, I20.0, 
I21-22, I50, I60-64. 
Median 
11.8 years. 
Database 
study. 
Catov 
20072 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
Self-reported. Excluded women 
who reported pre-
eclampsia or 
hypertension 
during pregnancy. 
Adjusted for race, age at study 
baseline, systolic BP, log 
pulse wave velocity (from 
simultaneous carotid and 
femoral artery Doppler flow 
signals), insulin resistance, log 
Self-reported and 
validated using an 
algorithm that 
assesses medication, 
physical examination, 
blood tests and ECG. 
Mean 57 
years. 
All women 
followed 
up. 
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IL-6, HDL cholesterol and 
statin use. 
Catov 
20103 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
Danish Medical 
Birth Registry. 
Excluded women 
with 
hospitalization for 
CVD or diabetes 
before the first 
birth during study 
period and those 
dying during 
delivery. 
Adjusted for maternal age at 
first birth, parity, education, 
birth year. Excluded pre-
eclampsia, SGA offspring and 
diabetes. 
ICD-8 and 10 codes 
from the National 
Hospital Discharge 
Register. 
 
ICD-8: 410-414, 430-
438, 440, 444, 452, 
453. 
ICD-10: I20-25.5, 
I60-69.8, I70-70.9, 
I74, I81, I82.  
Mean 28 
years. 
Database 
study. 
Cirillo 
20154 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From medical 
records. 
Not applicable as 
death outcome. 
Adjusted for age, race, parity, 
BMI and smoking. Excluded 
pre-existing heart disease, 
multiple births, gestations <20 
weeks and missing parity data. 
ICD-7 to 10 codes in 
data linkage to 
California Vital 
Statistics and 
National Death 
Index. 
 
ICD-7: 420.1. 
ICD-8: 410, 412. 
ICD-9: 410, 411, 414, 
429. 
ICD-10: I21, I24, I25. 
Median 40 
years. 
<10% loss 
to follow-
up. 
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Davey 
Smith 
20005 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From previous 
study records. 
Not applicable as 
death outcome. 
Adjusted for age, height, 
marital status, visits to private 
doctor, BP and hormone use 
during pregnancy, 
From Finnish Central 
Population and Cause 
of Death registers. 
Unclear. Unclear. 
Davey 
Smith 
20056 
General cohort 
of parents. 
Controls 
from the 
same 
cohort. 
From the 
Swedish 
Medical Birth 
Register. 
Not applicable as 
death outcome. 
Adjusted for birth weight. ICD-9 codes in the 
Swedish Cause of 
Death register. 
 
ICD-9: 390-459. 
Mean 20.4 
years. 
Unclear. 
Freibert 
20117 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
Self-reported. No. Unadjusted. Self-reported. Unclear. 92.3% of 
all eligible 
women had 
complete 
data. 
Hastie 
20118 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From routine 
national 
electronic 
records. 
No. Adjusted for age at delivery, 
height, deprivation category, 
birthweight decile, essential 
hypertension and pre-
eclampsia. 
ICD-8 to10 codes 
from electronic 
records. 
 
ICD-8/9: 410-414. 
ICD-10: I20-25. 
Mean 22 
years. 
Database 
study. 
Hovi 
20149 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
Finnish Medical 
Birth Register. 
No. Unadjusted. ICD-9 and 10 codes 
from the Hospital 
Discharge Register 
data and non-primary 
Up to 22 
years. 
<1% loss 
to follow-
up. 
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care outpatient visit 
data. 
 
No details on exact 
ICD codes used. 
Irgens 
200110 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
Medical Birth 
Registry of 
Norway. 
Not applicable as 
death outcome. 
Adjusted for age at delivery 
and year of birth of baby. 
Excluded pre-eclampsia. 
ICD-8 and 9 codes 
from the Registry of 
Causes of Death. 
 
ICD-8/9: 410-429. 
Median 13 
years. 
<10% loss 
to follow-
up. 
Kessous 
201311 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
hospital 
perinatal 
database. 
Excluded women 
with known CVD 
before or during 
the index 
pregnancy. 
Adjusted for diabetes, 
gestational diabetes, obesity, 
age, pre-eclampsia, ethnicity, 
anaemia and induction of 
labour. 
ICD-9 codes from the 
hospitalization 
database. 
 
ICD-9: 272.2, 272.4, 
401.9, 402, 404, 
404.9, 410, 411, 
411.8, 411.81, 413, 
413.9, 414, 414.8, 
414.9, 415, 415.0, 
427.5, 428.0, 428.1, 
428.9, 429.9, 429.2, 
436, 437, 437.1, 440, 
440.2, 443.8, 443.89, 
443.9, V810, V812, 
Z0045-Z0047, Z005, 
Mean 10 
years. 
Database 
study. 
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Z0065, Z3721-
Z3723, Z37211, 
Z3610, Z3619, 
Z8852-Z8857, 
Z8877, Z8941, 
Z8943, Z8944, Z895. 
Lykke 
2010a12 & 
Lykke 
2010b13 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
National Patient 
Registry in 
Denmark. 
Excluded pre-
existing diabetes, 
cardiovascular 
diagnosis and 
women who died 
or emigrated 3 
months after 
delivery. 
Adjusted for maternal age at 
delivery, year of delivery, 
hypertensive pregnancy 
disorders, SGA or large-for-
gestational-age offspring, 
placental abruption and 
stillbirth (Lykke 2010a).  
Adjusted for maternal age at 
delivery and year of delivery 
(Lykke 2010b). 
ICD codes from the 
National Patient 
Registry (Lykke 
2010a) or from cause 
of death registry or 
first cardiovascular 
diagnosis within 1 
week prior to death 
(Lykke 2010b). 
 
ICD-8: 39-44, 
45.145.8, 41.0-41.4, 
427.09-427.11, 
427.19, 427.99, 
428.99, 429.00, 
429.08, 429.09, 430-
438. 
 
Median 
14.6 years 
(Lykke 
2010a) or 
14.8 years 
(Lykke 
2010b). 
<10% loss 
to follow-
up. 
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ICD-10: G45, I0-9, 
I20-25, I50, I51.3, 
I51.9, I60-67. 
Nardi 
200614 
Teachers 
covered by a 
health 
insurance 
scheme. 
Controls 
from the 
same 
cohort. 
Self-reported. Not applicable as 
death outcome. 
 
Unadjusted. Excluded pre-
existing MI, angina, 
psychiatric disorders and 
unspecified other cardiac and 
non-cardiac diseases. 
Death from CHD 
using ICD-9 codes 
from insurance and 
national databases. 
 
ICD-9: 410-414. 
Mean 5.2  
years from 
study 
enrolment. 
19% loss to 
follow-up. 
Ngo 
201515 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
perinatal data 
collection. 
Excluded chronic 
hypertension or 
hypertensive 
disorders of 
pregnancy, CVD 
event prior to last 
birth, CVD event 
within 42 days of 
last birth and death 
Adjusted for age, country of 
birth, socioeconomic status, 
parity, SGA offspring, 
diabetes, gestational diabetes 
and smoking. 
ICD-10 codes from 
national datasets. 
 
ICD-10: G45.0-45.2, 
G45.4, G45.8, G45.9, 
G46, I20-25, I25.2, 
I50, I60-66, I67.0-
67.2, I67.4-67.9, 
I68.1, I68.2, I68.8, 
I69. 
Median 7.5 
years. 
Linkage 
proportion 
for records 
>98%. 
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before follow-up 
period.  
Pell 200416 
& Smith 
200117 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From routine 
maternity 
hospital 
records. 
No. Excluded stillbirths. Adjusted 
for age, height, deprivation 
category, pre-eclampsia, 
lowest birth weight quintiles 
and previous spontaneous 
miscarriage (Pell 2004). 
Additional adjustment for 
essential hypertension, but not 
previous miscarriage (Smith 
2001). 
ICD-9 and 10 codes 
from the Scottish 
Morbidity Record 
system and General 
Registrar’s Office. 
 
ICD-9: 410-414, 430-
438. 
ICD-10: G44, I-20-
25, I60-69,  
14-19 
years. 
11.9% 
(Pell 2004) 
or 4.4% 
(Smith 
2001) loss 
to follow-
up. 
Rich-
Edwards 
201518 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From the 
Medical Birth 
Registry of 
Norway. 
Not applicable as 
death outcome. 
Adjusted for year of delivery, 
age and education at first 
birth. 
ICD-8 to 10 codes in 
the National Cause of 
Death Registry. 
 
ICD-8/9: 410-414, 
430-438. 
ICD-10: I20-25, I60-
69. 
Median 
24.8 years. 
8.3% loss 
to follow-
up. 
Tanz 
201719 
Registered 
nurses. 
Controls 
from the 
same 
cohort. 
Self-reported. Excluded pre-
existing MI or 
stroke. 
Excluded hypertensive 
disorders of pregnancy. 
Adjusted for age at first birth, 
age in 1989, ethnicity, parental 
education, pre-pregnancy 
BMI, smoking, Alternative 
Self-reported then 
verified with medical 
records. 
Median 32 
years. 
32% of 
eligible 
women had 
missing 
data. 
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Healthy Eating Index score, 
alcohol intake, physical 
activity at 18 years of age, oral 
contraceptive use, chronic 
hypertension, 
hypercholesterolaemia, type 2 
diabetes and family history of 
MI or stroke before 60 years 
of age. 
Wang 
201120 
General cohort 
of women. 
Controls 
from the 
same 
cohort. 
From National 
Health 
Insurance 
program 
database. 
Excluded pre-
existing stroke or 
hypertension. 
Adjusted for age, urbanization 
level, diabetes, 
hyperlipidaemia, CHD, 
abruption, lupus and 
thrombophilia. 
ICD-9 codes from the 
national database. 
 
ICD-9: 430-437, 
674.0, A290-294, 
A299. 
Mean 6.4 
years. 
Database 
study. 
Wikstrom 
200521 
General cohort 
of women. 
Controls 
from 
same 
cohort. 
ICD codes from 
Swedish 
Medical 
Register.  
Excluded 
hypertension and 
diabetes. 
Adjusted for age, socio-
economic level, category of 
hospital in which the first 
child was born. 
ICD-9 and ICD-10 
codes from hospital 
discharge register and 
cause of death 
register. 
 
ICD-9: 410-414. 
ICD=10: I20-25. 
15 years. 3.15%  
died or 
emigrated. 
BMI=body mass index, BP=blood pressure, CHD=coronary heart disease, CVD=cardiovascular diseases, ECG=electrocardiogram, HDL=high-
density lipoprotein, IL=interleukin, MI=myocardial infarction, SGA=small-for-gestational age.
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Table S3. Cardiovascular risk factor profile of preterm birth and term birth groups in the 
included studies. GDM=gestational diabetes, HBW=high birth weight >2500g, LBW=low 
birth weight <2500g, BMI=body mass index, N.S.=non-significant, SE=socio-economic, 
SEIFA=socio-economic indexes for areas, SGA=small-for-gestational age, wk=weeks 
gestation. 
Study ID Risk factor 
profile 
During pregnancy / study 
enrolment 
At follow-up 
Preterm Term p 
value 
Preterm Term p 
value 
Bonamy 20111 Not available - - - - - - 
Catov 20072 Age (year) 23.1 HBW 
23.7 
- 72.9 HBW 
73.0 
- 
LBW 
22.0 
LBW 
73.4 
Black race (%) - - - 51.9 HBW 
41.5 
- 
LBW 
63.2 
Low SE status 
(%) 
- - - 22.2 HBW 
14.2 
- 
LBW 
18.4 
Ever smoker 
(%) 
- - - 66.7 HBW 
41.7 
- 
LBW 
47.4 
BMI (kg/m2) - - - 27.8 HBW 
28.3 
- 
LBW 
26.7 
Triacylglycerol 
(mg/dL) 
- - - 139.5 HBW 
141.3 
- 
LBW 
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163.7 
Fasting glucose 
(mg/dL) 
- - - 104.0 HBW 
101.4 
- 
LBW 
98.0 
Fasting insulin 
(IU/mL) 
- - - 9.8 HBW 
8.2 
- 
LBW 
10.7 
Hypertension 
(%) 
- - - 70.4 HBW 
59.8 
- 
LBW 
71.1 
Diabetes (%) - - - 7.7 HBW 
9.5 
- 
LBW 
7.9 
Catov 20103 Age (year) 25.2 25.7 - - - - 
Basic 
education (%) 
51.1 44.1 <0.001 - - - 
Pre-eclampsia 
(%) 
5.0 3.2 <0.001 - - - 
SGA (%) 13.1 9.2 <0.001 - - - 
Cirillo 20154 Not available - - - - - - 
Davey Smith 
20005 
Not available - - - - - - 
Davey Smith 
20056 
Not available - - - - - - 
Freibert 20107 Age (year) - - - 59.6 60.3 - 
Education ≤12 
years (%) 
- - - 38 36.4 - 
Ever smoker 
(%) 
- - - 44 40 - 
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Hastie 20118 Age (year) 24 25 <0.001 - - - 
High 
deprivation 
quintile using 
Carstairs index 
(%)  
7.9 6.7 <0.001 - - - 
Hypertension 
(%) 
0.4 0.1 <0.001 - - - 
Pre-eclampsia 
(%) 
8.8 8.1 <0.001 - - - 
Hovi 20149 Not available - - - - - - 
Irgens 200110 Not available - - - - - - 
Kessous 
201311 
Age (years) 28.1 29.9 0.001 - - - 
Jewish (%) 52.6 70.4 0.001 - - - 
GDM and 
Diabetes (%) 
8.3 8.2 N.S. - - - 
Obesity (%) 1.1 2.0 0.001 - - - 
Lykke 2010a12 
& Lykke 
2010b13 
Not available - - - - - - 
Nardi 200614 Not available - - - - - - 
Ngo 201515 High 
deprivation 
using SEIFA 
index (%) 
24.0 20.9 - - - - 
Ever smoker 
(%) 
30.0 28.3 - - - - 
Diabetes (%) 1.3 0.4 - - - - 
Pell 200416 & 
Smith 200117 
Not available - - - - - - 
Age (year) 23.7 23.9 - - - - 
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Rich-Edwards 
201518 
Education 
<high school 
(%) 
53.6 46.4 - - - - 
Tanz 201719 Age (year) <32 wk  
27.5 
27 - - - - 
≥32 to 
<37 wk 
27.8 
BMI≥30 (%) <32 wk 
4.0 
3.1 - - - - 
≥32 to 
<37 wk 
3.4 
Caucasian (%) <32 wk 
91.0 
92.9 - - - - 
≥32 to 
<37 wk 
90.9 
Ever smoker 
(%) 
<32 wk 
33.0 
31.8 - - - - 
≥32 to 
<37 wk 
30.9 
Wang 201120 Not available - - - - - - 
Wikstrom 
200521 
Not available - - - - - - 
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Table S4. Sensitivity analysis with regards to singleton and multiple pregnancies.  
 
Outcomes Singleton pregnancies only Singleton and multiple 
pregnancies 
CVD 
 
1.56 [1.27, 1.93], n=5 1.56 [1.32, 1.84], n=8 
CVD death 
 
1.95 [1.79, 2.12], n=4 1.81 [1.55, 2.10], n=5 
CHD 
 
1.48 [1.36, 1.61], n=4 1.50 [1.39, 1.62], n=6 
CHD death 
 
2.07 [1.76, 2.44], n=3 2.02 [1.78, 2.30], n=5 
Stroke 
 
1.69 [1.54, 1.85], n=3 1.65 [1.51, 1.79], n=5  
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Table S5. Sensitivity analysis with regards to the year each study was commenced. 
 
Outcomes Study year 
before 1990 
Study year  
after 1990 
Study year 
before 1970 
Study year  
after 1970 
CVD 1.51 [1.20, 1.90], 
n=5 
1.62 [1.46, 1.80], 
n=3 
- - 
CVD death - - 1.91 [1.68, 2.16], 
n=2 
1.74 [1.36, 2.23], 
n=3 
CHD 1.46 [1.34, 1.59], 
n=4 
1.64 [1.44, 1.87], 
n=2 
- - 
CHD death - - 2.17 [1.92, 2.46], 
n=3 
1.61 [1.26, 2.07], 
n=2 
Stroke 1.60 [1.33, 1.93], 
n=3 
1.67 [1.45, 1.93], 
n=2 
- - 
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Table S6. Sensitivity analysis with regards to study quality score.  
 
Outcomes Study quality score ≤6 Study quality score ≥7 
CVD 1.59 [1.38, 1.83], n=4 1.53 [1.18, 1.97], n=4 
CVD death 2.06 [1.22, 3.47], n=1 1.79 [1.51, 2.11], n=4 
CHD 1.65 [1.34, 2.03], n=2 1.48 [1.36, 1.61], n=4 
CHD death 1.54 [1.04, 2.28], n=1 2.10 [1.87, 2.36], n=4 
Stroke 1.55 [1.05, 2.29], n=2 1.67 [1.52, 1.83], n=3 
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Table S7. Sensitivity analysis with regards to study location. 
 
Outcomes Study location: 
Europe 
Study location: U.S. Study location: other 
CVD 1.54 [1.23, 1.92], n=5 1.73 [0.87, 3.46], n=2 1.65 [1.49, 1.82], n=1 
CVD death 1.81 [1.55, 2.10], n=5 - - 
CHD 1.45 [1.32, 1.60], n=3 1.65 [1.34, 2.03], n=2 1.61 [1.40, 1.86], n=1 
CHD death 1.98 [1.69, 2.33], n=4 2.10 [1.43, 3.08], n=1 - 
Stroke 1.70 [1.51, 1.90], n=2 1.28 [0.95, 1.72], n=1 1.67 [1.45, 1.93], n=2 
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Table S8. Sensitivity analysis with regards to whether the study excluded women with pre-existing cardiovascular disease. 
 
Outcomes Pre-existing CVD excluded Pre-existing CVD not excluded 
CVD 1.54 [1.24, 1.92], n=6 
 
1.65 [1.46, 1.85], n=2 
CVD death 1.98 [1.77, 2.21], n=2 1.54 [1.02, 2.33], n=3 
CHD 1.45 [1.33, 1.57], n=4 1.59 [1.48, 1.71], n=2 
CHD death - 2.02 [1.78, 2.30], n=5 
Stroke 1.63 [1.49, 1.78], n=4 1.91 [1.35, 2.70], n=1 
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Figure S1. PRISMA checklist 
 
PRISMA 2009 Checklist 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta-
Analysis. 
1 
ABSTRACT   
Structured summary  2 Background: Preterm delivery (<37 weeks gestational age) affects 11% of all pregnancies, but data are 
conflicting whether preterm birth is associated with long-term adverse maternal cardiovascular outcomes. 
Objectives: To systematically evaluate and summarize the evidence on the relationship between preterm 
birth and future maternal risk of cardiovascular diseases. 
Data sources: A systematic search was conducted using MEDLINE and EMBASE from inception to 
October 2017. Manual searching for additional articles was also conducted by reviewing the bibliography 
of relevant review articles and published systematic reviews. Search terms were: Synonyms of preterm 
birth (‘preterm delivery’ or ‘preterm birth’ or ‘premature delivery’ or ‘premature birth’) AND ‘ischaemic heart 
disease’ or ‘ischemic heart disease’ or ‘coronary artery disease’ or ‘coronary heart disease’ or ‘myocardial 
infarction’ or ‘acute coronary syndrome’ or ‘heart failure’ or ‘cardiac failure’ or ‘left ventricular systolic 
dysfunction’ or ‘stroke’ or ‘cerebrovascular disease’ or ‘cerebrovascular accident’ or ‘cardiomyopathy’ or 
‘peripheral vascular disease’ or ‘cardiovascular disease’ or ‘cardiovascular morbidity’ or ‘cardiovascular 
mortality’. 
Study selection: The included studies had at least two groups (one with preterm birth and one with term 
birth) and reported sufficient data to allow for accurate risk estimates to be calculated. There was no 
restriction based on language, cohort type, study design or duration of follow-up. 
Data extraction: Independent double data extraction was done by four reviewers using predefined data 
fields, including study quality indicators. 
Study appraisal and synthesis methods: Study quality was assessed based on the recommendations of 
the Newcastle-Ottawa Quality Assessment Scale for cohort studies. We used RevMan Version 5.3.5 
(Nordic Cochrane Centre) to conduct random effects meta-analysis using the inverse variance method for 
pooling log risk ratios (RRs). 
5 
 
 
 
6 
 
 
 
 
 
7 
 
 
 
8 
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Results: Twenty-one studies with over 5.8 million women, including over 338,000 women with previous 
preterm deliveries, were identified. Meta-analysis of studies that adjusted for potential confounders showed 
that preterm birth was associated with an increased risk of maternal future cardiovascular disease (risk 
ratio (RR) 1.43, 95% CI 1.18, 1.72), cardiovascular disease death (RR 1.78, 95% CI 1.42, 2.21), coronary 
heart disease (RR 1.49, 95% CI 1.38, 1.60), coronary heart disease death (RR 2.10, 95% CI 1.87, 2.36), 
and stroke (RR 1.65, 95% CI 1.51, 1.79). Sensitivity analysis showed that the highest risks occurred when 
the preterm deliveries occurred before 32 weeks gestation or were medically indicated. 
Limitations: The limitations of this study include the risk of confounding and being unable to attribute 
causality of future cardiovascular disease to preterm delivery. There may be inherent publication bias, 
recall bias or inaccuracies in historical data collection. Heterogeneity may have arisen due to differences 
in the study population, research methodology, period of conducting the study, and inherent differences 
between the studies. 
Conclusions: Preterm delivery is associated with an increase in future maternal adverse cardiovascular 
outcomes, including a two-fold increase in deaths due to coronary heart disease. These findings support 
the assessment of preterm delivery in cardiovascular risk assessment in women. 
Systematic review registration number: PROSPERO CRD42017068455 
 
 
 
16 
 
 
17 
INTRODUCTION   
Rationale  3 Preterm birth (<37 weeks gestational age) affects 11% of all pregnancies. Pregnancy is characterized by 
a challenge to the cardiovascular system. This physiological stress for most women is uncomplicated but 
for women who experience preterm birth, this adverse pregnancy outcome may serve to identify women at 
risk for cardiovascular disease who would not have been detected using traditional risk assessment tools 
at a time when it may be possible to alter their risk trajectory. It remains unclear whether preterm delivery 
is an independent risk factor for future cardiovascular disease or an early marker of women with 
background high-risk profiles for future cardiovascular disease. The pathogenesis of preterm birth remains 
poorly understood. 
5 
Objectives  4 To systematically evaluate and summarize the evidence on the relationship between preterm birth and 
future maternal risk of cardiovascular diseases, we reviewed studies that compared long-term adverse 
cardiovascular outcomes between women with and without preterm birth in postnatal women.  
6 
METHODS   
Protocol and registration  5 Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017068455 
Protocol registration number: PROSPERO CRD42017068455 
6 
Eligibility criteria  6 Participants: postnatal women. 
Comparisons: Preterm birth versus term birth. 
Outcome measures: ischaemic heart disease, coronary artery disease, coronary heart disease, myocardial 
infarction, acute coronary syndrome, heart failure, cardiac failure, left ventricular systolic dysfunction, 
6 
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stroke, cerebrovascular disease, cerebrovascular accident, cardiomyopathy, peripheral vascular disease, 
cardiovascular disease, cardiovascular morbidity, cardiovascular mortality. 
Study characteristics: the included studies had at least two groups (one with preterm birth and one with 
term birth) and reported sufficient data to allow for accurate risk estimates to be calculated. There was no 
restriction based on language, cohort type, study design or duration of follow-up.  
Information sources  7 Searches were conducted using the databases MEDLINE and EMBASE from inception to present. Manual 
searching for additional articles was also conducted by reviewing the bibliography of relevant review articles 
and published systematic reviews. The last search was run on 7th October 2017.  
7 
Search  8 Synonyms of preterm birth (‘preterm delivery’ or ‘preterm birth’ or ‘premature delivery’ or ‘premature birth’) 
AND ‘ischaemic heart disease’ or ‘ischemic heart disease’ or ‘coronary artery disease’ or ‘coronary heart 
disease’ or ‘myocardial infarction’ or ‘acute coronary syndrome’ or ‘heart failure’ or ‘cardiac failure’ or ‘left 
ventricular systolic dysfunction’ or ‘stroke’ or ‘cerebrovascular disease’ or ‘cerebrovascular accident’ or 
‘cardiomyopathy’ or ‘peripheral vascular disease’ or ‘cardiovascular disease’ or ‘cardiovascular morbidity’ 
or ‘cardiovascular mortality’. 
Supplemental 
methods 2. 
Study selection  9 Eligibility assessment was performed independently by 2 reviewers. Disagreements between reviewers 
were resolved by using the eligibility assessment by PW, who is a more experienced researcher. 
7 
Data collection process  10 Independent double data extraction was done by 4 reviewers using predefined data fields, including study 
quality indicators. Disagreements between reviewers were resolved by consensus. If no agreement could 
be reached, the decision was made by PW. The information was obtained from published data. 
7 
Data items  11 Data were collected on study design, year, country, number of participants, mean age, parity, cohort 
characteristics, definition and ascertainment of preterm birth, ascertainment of outcomes, timing of 
assessment, adequacy of follow-up and results. Where possible, we chose to pool adjusted risk estimates 
from primary studies and when these data were not available, raw data were used to calculate unadjusted 
risk estimates. 
7, 8 
Risk of bias in individual 
studies  
12 Each study was individually assessed for quality based on the recommendations of the Newcastle-Ottawa 
Quality Assessment Scale for cohort studies by independent reviewers. No studies were excluded following 
quality assessment. 
7 
Summary measures  13 We conducted random effects meta-analysis using the inverse variance method for pooling log risk ratios. 8 
Synthesis of results  14 Studies were pooled in meta-analysis with subgroups based on whether or not the study used adjustments 
to account for confounders. Statistical heterogeneity was assessed using the I2 statistic.  
8 
Risk of bias across 
studies  
15 In the case for an analysis where there is more than 10 studies and little evidence of heterogeneity, we 
planned to perform funnel plots to assess for publication bias. 
8 
Additional analyses  16 Sensitivity analysis was performed to consider the follow-up duration of the studies (<10 years, 10-30 years, 
and >30 years), gestation (<32 weeks versus 32-37 weeks) and recurrence (1 recurrence versus ≥2 
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recurrence) of preterm births, and whether the preterm births occurred spontaneously or were medically 
indicated.  
RESULTS  
Study selection  17 See flow diagram in figure 1.  Figure 1 
Study characteristics  18 See table 1. Table 1 
Risk of bias within 
studies  
19 See supplemental table 1 and 2.  Supplemental 
tables 1 and 
2. 
Results of individual 
studies  
20 See table 2, figures 2-4. Table 2, 
figures 2-4. 
Synthesis of results  21 See figures 2-4. Figures 2-4. 
Risk of bias across 
studies  
22 We did not perform funnel plots to assess for publication bias as less than 10 studies were included in each 
analysis.  
11 
Additional analysis  23 See table 3 and supplemental table 4. Table 3 and 
supplemental 
table 4. 
DISCUSSION  
Summary of evidence  24 We found that preterm delivery is associated with an increased maternal risk for future incident 
cardiovascular events, cardiovascular death, coronary heart disease events, coronary heart disease death 
and stroke. The adjusted risk ranged between 1.4 to 2–fold compared to those without a history of preterm 
birth. This increased risk is greatest in preterm births that occur before 32 weeks in gestation or in those 
that are delivered for medical indications such as fetal growth restriction or pre-eclampsia. For the 
composite cardiovascular disease and coronary heart disease outcomes, the risks are higher in women 
with a greater number of recurrent preterm births.  
13 
Limitations  25 Outcome level: The limitations of this study include the risk of confounding and being unable to attribute 
causality of future cardiovascular disease to preterm delivery. Heterogeneity may have arisen due to 
differences in the study population, research methodology, period of conducting the study, and inherent 
differences between the studies. 
16 
 by guest on M
ay 3, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
  
Review level: There may be inherent publication bias, recall bias or inaccuracies in historical data 
collection.  
Conclusions  26 In keeping with current recommendations, our study highlights the importance of advising women with 
preterm births about their increased cardiovascular risk and advocating and supporting lifestyle and 
behavioural changes to control their modifiable risk factors. These findings support the assessment of 
preterm delivery in cardiovascular risk assessment in women, with the 6-week postpartum visit the ideal 
place for this to occur. 
17 
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